Evidence map›Paper›PMID 23995958›Full record

ArticleDiabetes2013

γ-Aminobutyric acid regulates both the survival and replication of human β-cells.

Jide Tian, Hoa Dang, Zheying Chen, Alice Guan, Yingli Jin, Mark A Atkinson, Daniel L Kaufman

Open access · hybridAbstract read
In one paragraph

Article in Diabetes, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. The role of GABA in type 1 diabetes.Frontiers in endocrinology · 2024
    Review
  14. Review
  15. GABA signalling in human pancreatic islets.Frontiers in endocrinology · 2023
    Review
  16. Article
  17. Article
  18. Review
  19. The role of GABA in islet function.Frontiers in endocrinology · 2022
    Review
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jide TianDepartment of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, California.
Hoa Dang
Zheying Chen
Alice Guan
Yingli Jin
Mark A Atkinson
Daniel L Kaufman
University of California, Los Angeles · USUniversity of Florida · US

Funding

Reversal of T1D in NOD mice using a safe combination therapyR01DK092480 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KAUFMAN, DANIEL · 2012 to 2015
$1.3M
NIDDK NIH HHS DK-092480NIDDK NIH HHS R01 DK092480
6 · The paper itself

Abstract

γ-Aminobutyric acid (GABA) has been shown to inhibit apoptosis of rodent β-cells in vitro. In this study, we show that activation of GABAA receptors (GABAA-Rs) or GABAB-Rs significantly inhibits oxidative stress-related β-cell apoptosis and preserves pancreatic β-cells in streptozotocin-rendered hyperglycemic mice. Moreover, treatment with GABA, or a GABAA-R- or GABAB-R-specific agonist, inhibited human β-cell apoptosis following islet transplantation into NOD/scid mice. Accordingly, activation of GABAA-Rs and/or GABAB-Rs may be a useful adjunct therapy for human islet transplantation. GABA-R agonists also promoted β-cell replication in hyperglycemic mice. While a number of agents can promote rodent β-cell replication, most fail to provide similar activities with human β-cells. In this study, we show that GABA administration promotes β-cell replication and functional recovery in human islets following implantation into NOD/scid mice. Human β-cell replication was induced by both GABAA-R and GABAB-R activation. Hence, GABA regulates both the survival and replication of human β-cells. These actions, together with the anti-inflammatory properties of GABA, suggest that modulation of peripheral GABA-Rs may represent a promising new therapeutic strategy for improving β-cell survival following human islet transplantation and increasing β-cells in patients with diabetes.

Indexed as

AnimalsApoptosisBaclofenCell SurvivalDiabetes Mellitus, ExperimentalGABA-A Receptor Agonistsgamma-Aminobutyric AcidHeterograftsHumansInsulin-Secreting CellsIslets of Langerhans TransplantationMaleMiceMice, Inbred NODMuscimolReceptors, GABA-ABaclofenGABA-A Receptor Agonistsgamma-Aminobutyric AcidMuscimolReceptors, GABA-A

Identifiers

PMID23995958
PMCPMC3806626
OpenAlexW2150803022

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.